Edwards Lifesciences Corp. buy JPMorgan Chase & Co.
Start price
18.12.25
/
50%
€72.35
Target price
18.12.26
€85.19
Performance (%)
-8.22%
Price
10.04.26
€66.40
Summary
This prediction is currently active. With a performance of -8.22%, the BUY prediction for Edwards Lifesciences Corp. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 18.12.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Edwards Lifesciences Corp. | -5.480% | -5.480% |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences (NYSE:EW) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $100.00 price target on the stock, up previously from $90.00.
Ratings data for EW provided by MarketBeat